Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Child characteristics and receipt of stimulant medications: a population-based study.

Miller AR, Kohen D, Johnston C.

Ambul Pediatr. 2008 May-Jun;8(3):175-81. doi: 10.1016/j.ambp.2008.01.009.

PMID:
18501864
2.

Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.

Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.

Psychiatry Clin Neurosci. 2009 Apr;63(2):167-75. doi: 10.1111/j.1440-1819.2009.01937.x.

3.

Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.

Marcus SC, Wan GJ, Kemner JE, Olfson M.

Arch Pediatr Adolesc Med. 2005 Jun;159(6):572-8. Erratum in: Arch Pediatr Adolesc Med. 2005 Sep;159(9):875.

PMID:
15939858
4.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
5.

Predicting methylphenidate response in children with ADHD: theoretical, empirical, and conceptual models.

Denney CB, Rapport MD.

J Am Acad Child Adolesc Psychiatry. 1999 Apr;38(4):393-401.

PMID:
10199110
6.

Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.

Pelham WE, Burrows-Maclean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, Chacko A, Wymbs BT, Wienke AL, Walker KS, Hoffman MT.

Exp Clin Psychopharmacol. 2005 May;13(2):111-26.

PMID:
15943544
7.

Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis.

Marchetti A, Magar R, Lau H, Murphy EL, Jensen PS, Conners CK, Findling R, Wineburg E, Carotenuto I, Einarson TR, Iskedjian M.

Clin Ther. 2001 Nov;23(11):1904-21.

PMID:
11768842
8.

Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings.

Kolko DJ, Bukstein OG, Barron J.

J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):578-86.

PMID:
10230190
9.
10.

Treatment of attention deficit hyperactivity disorder in children. Predictors of treatment outcome.

van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM.

Eur Child Adolesc Psychiatry. 2008 Mar;17(2):73-81.

PMID:
17876505
11.

Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.

Walitza S, Melfsen S, Herhaus G, Scheuerpflug P, Warnke A, Müller T, Lange KW, Gerlach M.

J Neural Transm Suppl. 2007;(72):311-5.

PMID:
17982908
12.
13.
14.

No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.

Walitza S, Kämpf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, Warnke A, Gerlach M, Stopper H.

Toxicol Lett. 2009 Jan 10;184(1):38-43. doi: 10.1016/j.toxlet.2008.10.011.

PMID:
19015014
15.

Assessing methylphenidate preference in ADHD patients using a choice procedure.

Fredericks EM, Kollins SH.

Psychopharmacology (Berl). 2004 Oct;175(4):391-8.

16.

[The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].

Durukan I, Türkbay T, Cöngöloğlu A.

Turk Psikiyatri Derg. 2008 Winter;19(4):358-64. Turkish.

17.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
18.

Response of children with ADHD to methylphenidate: interaction with internalizing symptoms.

DuPaul GJ, Barkley RA, McMurray MB.

J Am Acad Child Adolesc Psychiatry. 1994 Jul-Aug;33(6):894-903.

PMID:
8083147
19.

Switching from methylphenidate immediate release to MPH-SODAS in attention-deficit/hyperactivity disorder.

Maia CR, Matte BC, Ludwig HT, Rohde LA.

Eur Child Adolesc Psychiatry. 2008 Apr;17(3):133-42.

PMID:
17846812
20.

An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.

Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J.

Expert Opin Investig Drugs. 2008 Jan;17(1):77-84. Review.

PMID:
18095920

Supplemental Content

Support Center